FIELD: medicine.
SUBSTANCE: method involves carrying out immunohistochemical analysis of withdrawn tumor cells to determine percentage of cells showing Bax expression with respect to general quantity of cancer cells in vision field, percentage of cells showing Bcl-2 expression, index disclosing relation between the values. The index value being less than 1.0, high metastasis progress probability is to be predicted.
EFFECT: high accuracy of prognosis.
2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING METASTASES OF UVEAL MELANOMA BASED UPON APOPTOSIS MARKERS BAX AND BCL-2 | 2003 |
|
RU2242766C1 |
| METHOD OF PREDICTION OF CLINICAL COURSE OF UVEA MELANOMA BASED ON APOPTHOSIS MARKER Bax | 2002 |
|
RU2208790C1 |
| METHOD PREDICTING CLINICAL COURSE OF UVEA MELANOMA BASED ON APOPTHOSIS MARKER p53 | 2002 |
|
RU2208789C1 |
| METHOD FOR PREDICTING UVEAL MELANOMA METASTASIS FORMATION ON THE BASIS OF BAX AND KI-67 MARKERS | 2003 |
|
RU2240560C1 |
| METHOD OF SIMULTANEOUS VERIFICATION AND PREDICTION OF COURSE OF UVEAL MELANOMA | 2006 |
|
RU2337362C1 |
| METHOD OF SIMULTANEOUS VERIFICATION OF UVEAL MELANOMA COURSE FORECAST | 2006 |
|
RU2327420C1 |
| METHOD FOR PREDICTION OF SURVIVAL RATE AFTER ENUCLEATION WITH UVEAL MELANOMA DEVELOPED TO EQUATOR | 2024 |
|
RU2822319C1 |
| METHOD FOR PREDICTING CLINICAL FLOW OF UVEAL MELANOMA | 2001 |
|
RU2193200C1 |
| METHOD FOR PREDICTING CLINICAL COURSE OF UVEAL MELANOMA DEVELOPMENT | 2001 |
|
RU2197731C2 |
| METHOD FOR PREDICTION OF RECURRENT SOFT TISSUE SARCOMAS | 2013 |
|
RU2532332C1 |
